Last10K.com

Quest Diagnostics Inc (DGX) SEC Filing 8-K Material Event for the period ending Wednesday, February 17, 2021

Quest Diagnostics Inc

HISTORY TOOLS
CIK: 1576169 Ticker: DGX

View differences made from one to another to evaluate Quest Diagnostics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Quest Diagnostics Inc.

Continue

Assess how Quest Diagnostics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Quest Diagnostics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover

Material Contracts, Statements, Certifications & more

Quest Diagnostics Inc provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Press Release
Ticker: DGX
CIK: 1022079
Form Type: 8-K Corporate News
Accession Number: 0000947871-21-000262
Submitted to the SEC: Tue Feb 23 2021 4:30:27 PM EST
Accepted by the SEC: Tue Feb 23 2021
Period: Wednesday, February 17, 2021
Industry: Medical Laboratories
Events:
  1. Event for Officers
  2. Financial Exhibit
  3. Other Events
  4. Regulated Disclosure

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/dgx/0000947871-21-000262.htm